Hypotheses
Self-reported PTSI symptoms and resilience
H1. Symptoms of PTSI will be significantly reduced following completion of the AMT
intervention, as measured by the Personal Health Questionnaire (PHQ-8), General Anxiety
Disorder Scale (GAD-7), Depression, Anxiety, and Stress Scale (DASS), PTSD checklist (PCL-5),
Copenhagen Burnout Inventory (CBI), Perceived Stress Scale (PSS), Alcohol Use Disorder
Identification Test (AUDIT). Occupational/operational stress exposure will be measured by the
Police Stress Questionnaire (PSQ) to account for possible exposures to stress and potentially
traumatic events over the course of the intervention. Self-reported and COVID related stress
will also be evaluated.
H2. Functional wellness capacity and resilience will be significantly improved following
completion of the AMT intervention, as measured by the Brief COPE, Resilience Scale for
Adults (RSA-33), and Brief Resilience Scale (BRS), White Bear Suppression Inventory (WBSI),
Perseverative Thinking Questionnaire (PTQ), Ultra-Brief Penn State Worry Questionnaire
(UB-PSWQ), Ultra-Brief Rumination Response Styles (UB-RRS), Good Health Practices Scale
(GHPS).
H3. Sex and gender differences in PTSI will be observed at baseline and post-intervention
assessment. We expect that females will report more symptoms of PTSI and lower resilience at
baseline, and a greater reduction of PTSI symptoms and greater increase in resilience at
follow-up than males. Gender role stress, discrimination, and harassment will be explored as
moderators of PTSI symptoms at baseline and in response to the AMT intervention. Sex is
measured by self-reported sex at birth, gender discrimination is measured by Workplace Gender
Discrimination Scale (WGDS) and harassment is measured by the Gender Experiences
Questionnaire (GEQ).
Objective biological indicators of PTSI symptoms and resilience
H4. Resting HRV will significantly increase following completion of the AMT intervention.
Changes in resting HRV will be measured by time and frequency domain parameters based on data
collected from the wearable HR monitors (e.g., high and low frequency HRV, LF/HF ratio, and
the root mean square of successive differences (RMSSD) as recommended in the standards of
practice for HRV analysis.
H5. RSA will significantly increase following completion of the AMT intervention. RSA is
measured by obtaining the respiratory frequency. Greater power at the respiratory frequency
indicates a higher level of RSA and will be analyzed using the gold standard HRV analysis
program, Kubios.
H6. Recovery from acute stress will significantly improve following completion of the AMT
intervention. Acute stress will be induced by completion of the online Paced Auditory Serial
Addition Test (PASAT) and the Stroop Emotion Face Interference Task. Acute stress recovery
will be assessed via a time domain measure of HRV (RMSSD).
H7. Based on inconsistencies in the extant literature, we will conduct exploratory analyses
of any potential sex and gender differences in HRV, RSA, and acute stress recovery at
baseline and post-intervention assessments. Although we expect to see improvements in
self-reported and objective measures of PTSI and resilience overall (i.e., independent of sex
and gender), we hypothesize that gender role stress and gender discrimination will moderate
these effects. Further, it is possible that the magnitude of post-intervention changes is
greater among women given the additional burden of exposure to a hyper-masculinized working
environment. Because AMT provides tools for effective stress management, women may find more
benefit from the intervention in managing the wider array of sociocultural stressors they
experience compared to males.